Related Experiment Video
Updated: May 7, 2026
13:45
Merkel Cell Polyomavirus Infection and Detection
Published on: February 7, 2019
Mumps in Poland in 2011
Małgorzata Lipke1, Iwona Paradowska-Stankiewicz
1Department of Epidemiology, National Institute of Public Health- National Institute of Hygiene, Warsaw, Poland. mgluchowska@pzh.gov.pl
Przeglad Epidemiologiczny
|September 18, 2013
Summary
Poland
Area of Science:
- Epidemiology
- Public Health
- Vaccinology
Background:
- Mumps cases declined in Poland by 2011, continuing a trend from previous years.
- This decline is attributed to the mandatory mumps vaccination program established in 2003, utilizing a two-dose MMR vaccine schedule.
- The MMR vaccine protects against mumps, measles, and rubella.
Purpose of the Study:
- To evaluate the epidemiological status of mumps in Poland during 2011.
- To compare the 2011 mumps incidence with data from preceding years.
Main Methods:
- Analysis of infectious disease data from the "Infectious diseases and poisoning in Poland in 2011" bulletin.
- Review of the "Preventative immunisation in Poland in 2011" bulletin.
- Utilized case definitions for infectious diseases (2009-2011) and the 2011 Preventative Vaccination Program.
Main Results:
- A total of 2585 mumps cases were reported in Poland in 2011.
- The incidence rate decreased to 6.7/100,000 from 7.2/100,000 in 2010, and was nearly half the 2005-2009 median.
- Children aged 5-9 years had the highest incidence rate (52.0/100,000); incidence was higher in men (7.9/100,000) than women (5.6/100,000).
- 24 individuals were hospitalized due to mumps in 2011.
Conclusions:
- Consistent adherence to the national vaccination schedule has led to a substantial reduction in reported mumps cases.
- The mumps vaccination program is effective in controlling the disease's spread.
Related Concept Videos
01:28Infectious Diseases and Their Occurrence
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
01:51Vaccinations
Overview
01:27Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:18Viral Meningitis
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...